During the past decade, Florida Research Center, Inc. conducted 19 clinical trials. In the 10-year time frame, 19 clinical trials started and 10 clinical trials were completed, i.e. on average, 52.6% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 10 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Florida Research Center, Inc." #1 sponsor was "Allergan" with 4 trials, followed by "Janssen Research & Development, LLC" with 4 trials sponsored, "ACADIA Pharmaceuticals Inc." with 2 trials sponsored, "Biohaven Pharmaceuticals, Inc." with 2 trials sponsored and "Eli Lilly and Company" with 2 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Florida Research Center, Inc." #1 collaborator was "Bavarian Nordic" with 1 trials as a collaborator, "Dermira, Inc." with 1 trials as a collaborator and "Takeda Development Center Americas, Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Florida Research Center, Inc." are "Gastroparesis" (4 trials), "Diabetes Mellitus" (3 trials), "Adjunctive Treatment of Major Depressive Disorder" (2 trials), "Atopic Dermatitis" (2 trials) and "Alzheimer's Disease" (1 trials). Many other conditions were trialed in "Florida Research Center, Inc." in a lesser frequency.

Most popular intervention types in "Florida Research Center, Inc." are "Drug" (17 trials), "Other" (4 trials), "Biological" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (13 trials), "Relamorelin" (3 trials), "Lebrikizumab" (2 trials), "Pimavanserin" (2 trials) and "AC-3933" (1 trials). Other intervention names were less common.

The vast majority of trials in "Florida Research Center, Inc." are 18 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Florida Research Center, Inc.". undefined are not yet recruiting, 5 are recruiting, 1 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 6 completed trials in Florida Research Center, Inc., undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Florida Research Center, Inc., 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".